Moreover, the PI3K/AKT/mTOR signaling pathway proteins were significantly elevated in PET/CT-positive HCC patients, suggesting that the activation of this pathway may be a key factor in the glycolytic phenotype of HCC cells (An et al., 2022). The gene discussed is MTOR; the disease is hepatocellular carcinoma.